Search research articles
Contact Us
Filters
Showing results (71-80 of 133) with videos related to
Page
of 14
Sort By:
Nutrients
|
August 10, 2024
When and How to Evaluate Vitamin D Status? A Viewpoint from the Belgian Bone Club
Bruno Lapauw, Michaël R Laurent, Serge Rozenberg, et al.
Archives of Osteoporosis
|
June 27, 2023
Risk factors predicting the 'time to first fracture' and its association with imminent fractures: a substudy of the FRISBEE cohort
Jeroen M K de Filette, Alexia Charles, Amélie Bellanger, et al.
Archives of Osteoporosis
|
April 24, 2020
Underevaluation of fractures by self-report: an analysis from the FRISBEE cohort
Felicia Baleanu, Michel Moreau, Virginie Kinnard, et al.
Current Medical Research and Opinion
|
December 15, 2018
Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in the United States
David Henry, Roger von Moos, Jean-Jacques Body, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 3, 2010
European French-speaking study from the GEMO group on bone metastases management: a special focus on external beam radiotherapy practice survey
Nicolas Magné, Cyrus Chargari, René Olivier Mirimanoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2006
A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer
Jean-Jacques Body, Thierry Facon, Robert E Coleman, et al.
Frontiers in Endocrinology
|
June 27, 2022
Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club
Michaël R Laurent, Stefan Goemaere, Charlotte Verroken, et al.
BMC Health Services Research
|
July 5, 2018
Physicians' preferences for bone metastases treatments in France, Germany and the United Kingdom
Yi Qian, Jorge Arellano, Francesca Gatta, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
January 29, 2013
Health state utilities for skeletal-related events secondary to bone metastases
Louis S Matza, Karen Chung, Kate Van Brunt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 25, 2009
Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates
Karim Fizazi, Allan Lipton, Xavier Mariette, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 133) with videos related to
Sort By:
Page
of 14
Nutrients
|
August 10, 2024
When and How to Evaluate Vitamin D Status? A Viewpoint from the Belgian Bone Club
Bruno Lapauw, Michaël R Laurent, Serge Rozenberg, et al.
Archives of Osteoporosis
|
June 27, 2023
Risk factors predicting the 'time to first fracture' and its association with imminent fractures: a substudy of the FRISBEE cohort
Jeroen M K de Filette, Alexia Charles, Amélie Bellanger, et al.
Archives of Osteoporosis
|
April 24, 2020
Underevaluation of fractures by self-report: an analysis from the FRISBEE cohort
Felicia Baleanu, Michel Moreau, Virginie Kinnard, et al.
Current Medical Research and Opinion
|
December 15, 2018
Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in the United States
David Henry, Roger von Moos, Jean-Jacques Body, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 3, 2010
European French-speaking study from the GEMO group on bone metastases management: a special focus on external beam radiotherapy practice survey
Nicolas Magné, Cyrus Chargari, René Olivier Mirimanoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2006
A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer
Jean-Jacques Body, Thierry Facon, Robert E Coleman, et al.
Frontiers in Endocrinology
|
June 27, 2022
Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club
Michaël R Laurent, Stefan Goemaere, Charlotte Verroken, et al.
BMC Health Services Research
|
July 5, 2018
Physicians' preferences for bone metastases treatments in France, Germany and the United Kingdom
Yi Qian, Jorge Arellano, Francesca Gatta, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
January 29, 2013
Health state utilities for skeletal-related events secondary to bone metastases
Louis S Matza, Karen Chung, Kate Van Brunt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 25, 2009
Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates
Karim Fizazi, Allan Lipton, Xavier Mariette, et al.
Page
of 14